The Czech Republic has long been known as one of the European countries with a highly developed health care system. Although not the richest and most developed country in Europe, the health system has always been invested and developed by the Czech government to bring the highest quality health care to people.
Dr. Ivan Reich graduated from the
Faculty of Medicine – Charles University, Prague – one of the oldest and
prestigious universities in Europe. He received intensive training in
Obstetrics in Italy, the Netherlands, Denmark and infertility treatment – IVF
in the Republic of Israel. He is one of the founders and executives of the
ISCAR IVF Center – the largest Israeli-assisted reproductive center in the
capital Prague, Czech Republic, which is considered one of the leading European
countries for assisted reproductive technologies.
How has the Czech government invested in the healthcare system?
Dr. Ivan Reich said that the current cost of healthcare in the Czech Republic is relatively high, but still low compared to other countries. For example, in 2007, this figure accounted for only 6.8% of gross domestic product (GDP), while the average in OECD countries (Organization for Economic Cooperation and Development) was 8.9% of GDP.
The cost of healthcare in the Czech Republic is low even when compared in absolute terms per capita in purchasing power parity. As in 2007, this number reached $ 1,626, while the average value for all OECD member states was $ 2,984. The highest per capita expenditure is still the United States ($ 7,290), followed by Norway, Switzerland, and Luxembourg.
And every year, health spending in OECD countries tends to increase by an average of 4%. As a result, health care costs are increasing year by year. This means that we will spend more and more on health care.
Calculations show that in the next ten years, the cost of health in the Czech Republic may increase by 150 billion Korun. The budget for gene therapy (treatment) during this period is likely to reach 30 billion Korun.
The current level of health and quality of health services in the Czech Republic
Although not a country that invests too much in health like the US (16% of GDP), France (11% of GDP), Switzerland (10.8% of GDP) or Germany (10.4%), the level Czech health is particularly high. The vast majority of indicators (parameters) from surveys, statistics or research show that the Czech treatment results are as high as the most developed countries in the world. Especially among them, the low perinatal mortality rate (the number representing the development of obstetrics and neonatology) and the treatment of cardiovascular events have achieved remarkable results.
The number of acute hospital beds in the Czech Republic is decreasing, as in the rest of the OECD region, with an average of 3.8 beds per 1,000 people. In recent years, the average length of hospital stay has decreased and the number of outpatient medical procedures (interventions) has increased. This is a clear demonstration of the effectiveness of health service delivery.
Thanks to the improvement in living conditions and progress in medical care, the average life expectancy of the Czech people is increasing. The expected life expectancy for those born in 2007 in the Czech Republic is 76.7. The infant mortality rate is also very low – 3.3 deaths per 1,000 live births.
What will the Czech people spend on healthcare?
Medical expenses are probably not a big problem for the Czech people. Because in the Czech Republic, people will pay for health care at the lowest level, when more than 90% of treatment costs are paid by public insurance companies.
In most countries, patients pay most of the cost, but some drugs are provided free of charge (from health insurance). According to an OECD report in 2007, people in the Czech Republic had to pay nearly 30% of the cost of medicines, only in the Grand Duchy of Luxembourg, which is a country where people have to pay less (under 23). %). However, in countries outside of Europe, people have to pay more than 50% to pay for medicines, in America even more than 75%.